J amp;J Reportedly Eyes Guidant Johnson  amp; Johnson (JNJ:NYSE - news - research) reportedly is negotiating to buy Guidant (GDT:NYSE - news - research) for \$24 billion, a transaction that would unite two big manufacturers of coronary devices.